Philip E Baker

Philip E Baker i

University of Oxford - Oxford / United Kingdom
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1227217
person_outline Philip E Baker's MOST POPULAR ARTICLES
1-) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial The Lancet 396 (10249), 467-478, 2020
2-) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial The Lancet 396 (10267), 1979-1993, 2020
3-) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial The Lancet 397 (10282), 1351-1362, 2021
4-) Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses Nature medicine 27 (2), 279-288, 2021
5-) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) The Lancet 398 (10304), 981-990, 2021